Lung Cancer Treatments Lincoln NE

Radiotherapy plus chemotherapy, with or without surgery, works well for people with stage 3A non-small-cell lung cancer, a new study has found.

Phillip R Hynes
(402) 327-7300
201 South 68th Street Place
Lincoln, NE
Specialty
Radiation Oncology

Data Provided by:
Nathan B Green
(402) 420-7000
201 S 68th Street Pl
Lincoln, NE
Specialty
Hematology / Oncology

Data Provided by:
Wallace Carroll Peterson, MD
(402) 420-7000
201 S 68th Street Pl Ste 200
Lincoln, NE
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Ne Coll Of Med, Omaha Ne 68198
Graduation Year: 1982

Data Provided by:
Bennett R Barrios
(402) 327-7300
201 S 68th Street Pl
Lincoln, NE
Specialty
Radiation Oncology

Data Provided by:
Leonard Le, MR
(402) 489-8821
120 Wedgewood Dr Ste A
Lincoln, NE
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Mark D Carlson
(402) 420-7000
201 S 68th Street Pl
Lincoln, NE
Specialty
Hematology / Oncology

Data Provided by:
Undine Jean Howell-Burke
(402) 219-7930
555 S 70th St
Lincoln, NE
Specialty
Radiation Oncology

Data Provided by:
Alan R Berg
(402) 420-7000
201 S 68th Street Pl
Lincoln, NE
Specialty
Hematology / Oncology

Data Provided by:
Stacey K Knox
(402) 420-7000
201 S 68th Street Pl Ste 200
Lincoln, NE
Specialty
Hematology / Oncology

Data Provided by:
Alan Richard Berg, MD
(402) 484-4900
201 South 68th Place Ste 200
Lincoln, NE
Specialties
Oncology (Cancer), Internal Medicine
Gender
Male
Education
Medical School: Univ Of Nd Sch Of Med, Grand Forks Nd 58201
Graduation Year: 1980

Data Provided by:
Data Provided by:

Lung Cancer Treatments

Provided By:

MONDAY, July 27 (HealthDay News) -- Radiotherapy plus chemotherapy, with or without surgery, works well for people with stage 3A non-small-cell lung cancer, a new study has found.

Stage 3A is declared when surgery cannot cure the disease because it has spread to the lymph nodes in the center of the chest.

Non-small-cell lung cancer accounts for about 80 percent of lung cancers, and smoking tobacco is the most common cause of lung cancer. According to the U.S. National Cancer Institute, the risk of lung cancer is linked to the earlier in life a person starts smoking, the more often a person smokes and the more years a person smokes.

For the study, a research team led by Dr. Kathy Albain of Loyola University Chicago Stritch School of Medicine in Maywood, Ill., compared 202 patients who underwent chemotherapy plus radiotherapy followed by surgery with 194 patients who underwent chemotherapy plus radiotherapy alone, which is the current standard for these patients.

The researchers looked at the overall survival rates of the 396 patients after five years to draw their conclusions. They found no statistically significant difference in overall survival.

In an exploratory analysis, the researchers found that overall survival did improve for patients who only had part of a lung removed (lobectomy) rather than an entire lung. They speculated that removing an entire lung left patients more likely to die from acute respiratory distress syndrome or other respiratory diseases.

"On the basis of the findings of our study, patients should be counseled about the risks and potential benefits of definitive chemotherapy plus radiotherapy with, and without, a surgical resection (preferably by lobectomy)," the authors concluded.

The findings appear in the July 27 online edition of The Lancet.

More information

Learn more about non-small-cell lung cancer from the U.S. National Cancer Institute.

SOURCE: The Lancet, news release, July 26, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com